Drugmakers Test New Ways to Pay for Six-Figure Treatments


Drugmakers are experimenting with new ways to get paid for their most expensive medicines, as resistance to escalating prices builds and the collection and analysis of patient data improves. Now that six-figure price tags are common, drug companies are finding creative ways to get reimbursed, from installment plans and subscriptions to more complex value-based contracts that tie payment to when a drug helps a patient.